3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow EBV: new trials by email Literature Review of EBV trials Research Report on EBV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of an Epstein-Barr Virus (EBV) gp350-Ferritin Nanoparticle Vaccine in Healthy Adults EBV gp350-Ferritin Vaccine - EBV, Epstein-Barr Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 83 | 2022-03-29 | 2026-08-13 |
| Allogeneic Multivirus - Directed Cytotoxic T Lymphocytes (CTL) CTL for CMV seropositive donors, CTL for CMV naïve donors - EBV, CMV | Phase 1 | Completed | Catherine Bollard | 27 | 2014-02-01 | 2025-07-03 |
| Cytotoxic T Cells to Prevent Virus Infections Cytotoxic T lymphocytes (CTLs). - CMV, EBV | Phase 1 | Completed | Children's National Research Institute | 10 | 2013-09-01 | 2020-07-14 |
Adenoviridae Infections (2) · Epstein-Barr Virus Infections (1) · Infectious Mononucleosis (1)
DNA Virus Infections (3) · Infections (3) · Virus Diseases (3) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Herpesviridae Infections (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukocyte Disorders (1) · Lymphatic Diseases (1) · Lymphoproliferative Disorders (1) · Tumor Virus Infections (1)
Catherine Bollard (1) · Children's National Research Institute (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
United States (3)
Catherine Bollard, MD (1) · Catherine M Bollard, M.D (1) · Jessica R Durkee-Shock, M.D. (1)